January 2001
Indigent
Prescription Programs
Alza Pharmaceuticals Indigent Patient Assistance Program
Testoderm
Ocusert
Progestasert
(415) 962-4297
ALZA/U.S. Bioscience, Inc
Ethyol (amifortine) Access Program
Ethyol (amifortine) 1-800-609-1083
Amgen
Safety Net Epogen
Neupogen (800) 272-9376 or
(202) 637-6698
Astra Merck Inc.
Patient Assistance Program
Plendil
Prilosec
Tonocard 800-355-6044
Astra USA, Inc.
F.A.I.R. Program
Foscavir
(800) 488-3247
Bayer
- Pharmaceutical Bayer Indigent Patient Program
Most Bayer Prescription Products (800) 998-9180
Boehringer Ingelheim
Partner in Health
Alupent
Atrovent
Catapres-TTS
Mexitil
Serentil
(800) 556-8317
Bristol-Myers Squibb
Patient Assistance Program
Many Bristol-Meyers Squibb Pharmaceutical Products
(800) 736-0003
Ciba Pharmaceuticals
Patient Support Program
Many Ciba Products
(800) 257-3273
Dupont Merck Pharmaceutical Company
Patient Assistance Program
All non-controlled Prescription Products
(800) 474-2762
Fisions Pharmaceuticals
Indigent Access Program Intal
Tilade (610) 454-8110
Fujisawa USA, Inc
Indigent Patient Program
NebuPent
(847) 317-8874 or
(847) 317-8617
Genentech, Inc.
Uninsured Patient Assistance Program
Actmmune
Actvase
Protropin
Nutropin
(800)879-4747
Gilead Sciences, Inc.
Gilead Sciences Support Services Vistide
(800) 445-3235
Glaxo Wellcome, Inc.
Patient Assistance Program
All Glaxo Wellcome Prescription Products
(800) 722-9294
Hoechst Marion Roussel, Inc.
Indigent Patient Program
All prescription products except, Rifadin, Rifamate, Rifater and
Tenuate
(800) 221-4025
Janssen Pharmaceutica
Patient Assistance Program
All Jansen's prescription products
(800) 544-2987
Knoll Pharmaceutical Company
Indigent Patient Program Isoptin
Rhyhmol
Collagenase Santyl
Synthroid Write to:
Knoll Indigent Patient Program
Knoll Pharmaceutical Company
3000 Contenental Drive, North
Mount Olive, NJ 07828-1234
Att: Telemarketing
Lederile Laboratories
Partners in Patient Care, Assistance Program
Most Prescription Drugs
(703) 706-5933
Eli Lilly and Company
Lilly Cares
Most Lilly prescription products
(800) 545-6962
for Gemzar call
(888) 443-6927
The Liposome Company
Financial Asststance Program for Abelect Abelcet
(800) 335-5467
McNeil Pharmaceutical
Patient Assistance Program
All prescription products (800) 281-5192
Merck Human Health
Patient Assistance Program
Most Merck products (800) 994-2111
for Crixivan call
(800) 850-3430
Ortho-Biotech Inc.
Financial Assistance Program
Procrit
Leustatin
(800) 553-3851
Ortho Pharmaceutical Corp.
Patient Assistance Program
All prescription products
(800) 281-5192
Par Pharmaceutical, Inc.
Patient Assistance Program
Doxepin
Fluphenazine
Haloperidol
Megestrol
1-800-828-9393, ext.774
Parke-Davis
Patient Assistance Program
Accupril
Cognex
Dilantin
Loestrin
Neurontin
Zarontin
(908) 725-1247
Pasteur Merieux Connaught
Indigent Patient Program
Imovax
Imogam
TheraCys
(800) 822-2463
Pfizer Inc.
Pfizer Prescription Assistance
Most Pfizer products
(800) 646-4455
for Diflucan and Zitromax call
(800) 868-9979
For certain Pfizer single-source products call
Sharing the Care
(800) 984-1500
In Arkansas call
The Arkansas Heath Care Access Foundation at
(800) 9508233 or (501) 221-3033
In Kentucky call
Kentucky Health Care Access Foundation at
(800) 633-8100 or
(502) 244-4214
In S. Corolina call
Commun-I-Care at
(800) 7630059 or
(803) 779-4875
Pharmacia and Upjohn
Prescription Medication Assistance Program
Most prescription products
For Self-Administered products call(800) 242-7014
For Non Self-Administered products call (800) 366-5570
Procter and Gamble Pharmaceuticals Inc.
Patient Assistance Program
Asacol
Dantrium
Didronel
Macrodantin
Macrobid
(800) 448-4878
Rhône-Poulenc Rorer, Inc.
Indigent Access Program
Most prescription products
(610) 454-8110
Roche Laboratories
Roche Medical Needs Program
Most Roche and former Syntex product line (800) 285-4484
Roxane Laboratories, Inc
Patient Assistance Program
Marinol
Oramorph
Roxanol
Roxicodone
Viramune
(800) 274-8651
Sandoz Pharmaceuticals Corp.
Patient Assistance Program
Clozaril
Neoral
Sanimmune
Sandoglobulin
Sandostatin
Parodel
(800) 999-6673
Sanofi Winthrop Pharmaceuticals
Needy Patient Program
Most of their product line
(800) 446-6267
Schering Labs / Key Pharmaceuticals
Commitment to Care
Most Schering/Key prescription drugs
(800) 656-9485
Searle
Patients in Need
Many of the prescription drugs
(800) 542-2526
Serono Laboratories, Inc.
Helping Hand Program
Metrodin
Fertinex
Serostim
(617) 982-9000
SmithKline Beecham Pharmaceuticals
Access to Care Program
Most of their product line (800) 546-0420
for Oncology products call (800) 699-3806
Solvay Pharmaceuticals, Inc.
Patient Assistance Program
Most of their product line
(800) 788-9277
3M Pharmaceuticals
Ingigent Patient Pharmaceutical Program
Most drug products
(800) 328-0255
TAP Pharmaceuticals
Ingigent Patient Pharmaceutical Program
Prevacid
800-453-8438
Wyeth-Ayerst Laboratories
Norplant Foundation Norplant
(703) 706-5933
Zeneca Pharmaceuticals
Patient Assistance Program
Most of their product line
(800) 424-3727
*******************************************************
More free med programs
Pharmaceuticals & Biologicals
ALZA Pharmaceuticals
Ethyol® (amifostine) Reimbursement Assistance Program
Monday-Friday, 9 a.m.-5 p.m., CST
(800) 609-1083
ALZA Pharmaceuticals, in cooperation with U.S. Bioscience, has
established the Ethyol® (amifostine) Reimbursement Assistance
Program
to provide coverage, coding, and payment information to health care
professionals for Ethyol®. Ethyol® is indicated to reduce the
cumulative renal toxicity associated with repeated administration of
cisplatin in patients with advanced ovarian cancer or non-small cell
lung cancer. Program specialists will also provide assistance with
claim denials and payer advocacy upon request.
Amgen Inc.
Amgen Reimbursement Hotline
Monday-Friday, 9 a.m.-5 p.m., EST
(800) 272-9376.
The Amgen Reimbursement Hotline is a free information resource
available to those who use or administer NEUPOGEN® (filgrastim),
also
known as granulocyte colony stimulating factor. The hotline provides
information on reimbursement policies, billing procedures and codes,
and claims appeals for medically appropriate uses of NEUPOGEN®.
Reimbursement specialists maintain a database of insurer billing
information and provide information on NEUPOGEN® reimbursement.
The
hotline provides information about Amgen's Safety Net® Program,
which
provides NEUPOGEN® free of charge to sponsors of medically
indigent
patients who are under-or uninsured and have limited financial
resources. The hotline refers indigent patients to appropriate
available state or county-based funding.
Berlex Inc.
FLUDARA® (fludarabine phosphate) FOR INJECTION Reimbursement
Hotline
Monday-Friday, 8:30 a.m.-4:30 p.m., EST
(800) 473-5832
FLUDARA® FOR INJECTION is an IV drug indicated for the treatment
of B-
cell chronic lymphocytic leukemia. The FLUDARA® FOR INJECTION
Reimbursement Hotline assists health care professionals with drug
reimbursement information, billing guidelines, and claims assistance.
The hotline may be used for troubleshooting claims and is provided
free of charge. Berlex also established the FLUDARA® FOR INJECTION
Patient Assistance Program to provide FLUDARA® FOR INJECTION to
indigent patients.
Bristol-Myers Squibb Oncology/Immunology
Reimbursement Assistance Program (RAP[TM])
Monday-Friday, 8:30 a.m.-5 p.m., EST
(800) 872-8718
The service is designed to assist callers from the medical community
with reimbursement issues surrounding all Bristol-Myers Squibb
Oncology and Immunology products. The hotline is staffed by trained
reimbursement specialists who will provide information on third-party
coverage guidelines, claim requirements of individual third-party
payers, limitations of specific policies, drug and procedures coding,
and names and addresses of third-party payers. The hotline offers
assistance in providing details on claim form submission, identifying
reasons for claim rejection, providing guidelines and literature for
claim appeals, facilitating prior authorization requests, and
contacting insurers when appropriate in the process of claim
submission. Use of the RAP hotline is free of charge and there is no
limit to the number of times a provider may use the program. The
hotline is designed for providers in the United States.
Chiron Therapeutics
Proleukin® Reimbursement Hotline
Monday-Friday, 8 a.m.-5 p.m., PST
or leave a message after hours at (800) 775-7533.
Proleukin® (aldesleukin for injection), a recombinant
interleukin-2
(rIL-2), is approved for metastatic renal cell carcinoma and
metastatic melanoma. The Proleukin® Reimbursement Hotline helps to
minimize claims-processing delays.
Reimbursement specialists provide information about coding, prior
authorization procedures, patient coverage status, and reimbursement
amounts and limitations. They can also determine the status of and
reasons for denied claims and assist with filing appeals for denied
claims.
Cytogen Corporation
Cytogen Reimbursement Hotline
Monday-Friday, 9 a.m.-5 p.m., EST
(800) 282-5656
Reimbursement specialists are available to assist physicians and
institutions with billing, coding, and reimbursement questions
pertaining to public payers and private insurers. OncoScint® CR/OV
is
a monoclonal antibody-based imaging agent used to detect extrahepatic
malignant disease in patients with known colorectal or ovarian
cancer. ProstaScint® is a monoclonal antibody-based diagnostic
imaging agent for use in newly diagnosed patients with biopsy proven
prostate cancer thought to be clinically localized after standard
diagnostic evaluation and who are at high risk for pelvic lymph node
metastases and post-prostatectomy patients with a rising prostate-
specific antigen (PSA) and a negative or equivocal standard
metastatic evaluation in whom there is a high clinical suspicion of
occult metastatic disease.
Genentech, Inc.
Genentech Reimbursement Hotline
Monday-Friday, 8 a.m.-5 p.m., PST
(800) 530-3083
Reimbursement specialists provide information, counseling, and even
hands-on assistance for problems with reimbursement for Genentech
products: Actimmune® (interferon gamma-1b), Activase®
(alteplase,
recombinant), Nutropin® (somatropin [rDNA origin] for injection),
Protropin® (somatrem for injection), and Pulmozyme® (dornase
alfa).
Information regarding Genentech programs, established to provide
medically indicated products to patients who are uninsured and have
limited financial resources, is also provided.
Single Point of Contact (SPOC)
9 a.m.-8 p.m. EST
(888) 249-4918; Fax (888) 249-4919
Genentech® BioOncology's SPOC provides timely, one-step
reimbursement
assistance. Oncology nurse case managers will assist callers by:
investigating benefits for new patients and those changing insurance
or facing open enrollment; assisting with prior authorizations and
medical reviews; helping with appeals and coverage denials; searching
for alternative coverage for patients whose payers do not adequately
cover Genentech® BioOncology products; answering questions related
to
product reimbursement; and consulting on coding/billing issues.
Financial services include uninsured patient programs and office
finance programs provided by an independent organization.
Glaxo Wellcome
Oncology Reimbursement Hotline
Monday-Friday, 9 a.m.-5 p.m., EST
(800) 745-2967
The hotline serves clinicians, office staff, and patients and answers
questions related to coverage and reimbursement of all Glaxo Wellcome
Oncology products. Reimbursement specialists assist with claims
submissions, appeals, and prior authorizations for any of the
following products:
Navelbine® (vinorelbine tartrate), Alkeran® (melphalan),
Leukeran®
(chlorambucil), Myleran® (busulfan), Purinethol®
(mercaptopurine),
Tabloid® (thioguanine), and Wellcovorin® (leucovorin calcium).
Patient Assistance Program for Oncology Products
Monday-Friday, 9 a.m.-9 p.m., EST
(800) 722-9294
The Glaxo Wellcome Patient Assistance Program for Oncology Products
is designed to provide financially disadvantaged individuals rapid
access to any Glaxo Wellcome prescription medicine at no cost.
Potential candidates are those patients who cannot afford therapy and
are uninsured, and who do not qualify for publicly funded medication
assistance programs or are in the process of applying for such
programs.
Drug Information Services
(800) 334-0089
Searches for federal, state, or local reimbursement agencies to help
patients with payment. When patients call, a reimbursement specialist
will ask about insurance prescription coverage, monthly household
income earned or unearned, monthly medical expenses, and disability
status. Based on this information, we will determine if patients
qualify for federal, state, or local assistance. We will also provide
them with the addresses and telephone numbers of these programs so
that they can apply.
Zofran® (ondansetron) Reimbursement Hotline
Monday-Friday, 9 a.m.-5 p.m., EST
(800) 745-2967
The Zofran® Reimbursement Hotline was established to assist
providers
with billing for Zofran®, a breakthrough antiemetic for
chemotherapy
patients. The hotline provides physicians and hospitals with
information on coverage, coding, and reimbursement for Zofran®.
Assistance with problem claims is also available.
Hoechst Marion Roussel
ANZEMET® (dolasetron mesylate injection/tablets) Reimbursement &
Patient
Assistance Programs
Monday-Friday, 9 a.m.-5 p.m., CST
(888) 895-2219
Hoechst Marion Roussel has established the toll-free Anzemet®
Hotline
as a resource to providers to access reimbursement and patient
assistance information. Program specialists are available to help
with coverage status and benefit verification, claim submission and
coding guidelines, payment policies, and assistance with any rejected
or denied claims. They can also identify alternative sources of
coverage and provide applications for the Anzemet® Patient
Assistance
Program.
IMMUNEX® Corporation
Immunex Reimbursement Hotline
Monday-Friday, 8:30 a.m.-5:30 p.m., EST
(800) 321-4669
The Immunex Reimbursement Hotline offers third-party billing
information for LEUKINE® (sargramostim), NOVANTRONE®,
(mitoxantrone
HCL), and THIOPLEX® (thiotepa for injection) and also for
LEUCOVORIN
CALCIUM and METHOTREXATE SODIUM Parenteral. Reimbursement specialists
provide reimbursement assistance to identify informational
requirements of individual insurers, to facilitate prior
authorization requests, and to assist in appeals of denied claims.
The hotline provides one-on-one help with claims filing guidelines,
including CPT-4 and HCPCS coding. A dedicated fax machine is
available 24 hours at (800) 944-3184. These services are available
free of charge to health care professionals.
Lilly Oncology
Gemzar® (gemcitabine HCL) Reimbursement Hotline
Monday-Friday, 8 a.m.-5 p.m. CST
888-4-GEMZAR (888-443-6927)
The Reimbursement Hotline is a service provided free of charge by Eli
Lilly and Company and the Eli Lilly and Company Foundation. Program
reimbursement specialists are available to provide insurer coverage
guidelines, offer coding information and claims requirements, clarify
insurer payment methodologies, assist with prior authorization and
claims denials, and supply medical literature and information to
support claims. Information for the Patient Assistance Program,
designed to provide access to Gemzar therapy for financially
disadvantaged patients, is also available.
MGI PHARMA, INC.
Salagen® Tablets/Dry Mouth Information Helpline
Monday-Friday, 9 a.m.-5 p.m., EST
(800) 644-4811
The Salagen® Tablets (pilocarpine hydrochloride)/Dry Mouth
Information
Helpline meets the needs of health care providers and their patients
with dry mouth caused by Sjogren's syndrome or radiation to the head
and neck.
Registered pharmacists are available to provide educational materials
and se
**************************
A History of
Secret U.S. Government Programs -- WOW, is this for REAL?
A History of Secret U.S. Government Programs
The following is a list of this century's most controversial government
activities. It will be updated regularly in order to keep readers abreast of
newly declassified materials:
1931
Dr. Cornelius Rhoads, under the auspices of the Rockefeller Institute for
Medical Investigations, infects human subjects with cancer cells. He later
goes
on to establish the U.S. Army Biological Warfare facilities in Maryland, Utah,
and Panama, and is named to the U.S. Atomic Energy Commission. While there, he
begins a series of radiation exposure experiments on American soldiers and
civilian hospital patients.
1932
The Tuskegee Syphilis Study begins. 200 black men diagnosed with syphilis are
never told of their illness, are denied treatment, and instead are used as
human guinea pigs in order to follow the progression and symptoms of the
disease. They all subsequently die from syphilis, their families never told
that they could have been treated.
1935
The Pellagra Incident. After millions of individuals die from Pellagra over a
span of two decades, the U.S. Public Health Service finally acts to stem the
disease. The director of the agency admits it had known for at least 20 years
that Pellagra is caused by a niacin deficiency but failed to act since most of
the deaths occured within poverty-striken black populations.
1940
Four hundred prisoners in Chicago are infected with Malaria in order to study
the effects of new and experimental drugs to combat the disease. Nazi doctors
later on trial at Nuremberg cite this American study to defend their own
actions during the Holocaust.
1942
Chemical Warfare Services begins mustard gas experiments on approximately
4,000
servicemen. The experiments continue until 1945 and made use of Seventh Day
Adventists who chose to become human guinea pigs rather than serve on active
duty.
1943
In response to Japan's full-scale germ warfare program, the U.S. begins
research on biological weapons at Fort Detrick, MD.
1944
U.S. Navy uses human subjects to test gas masks and clothing. Individuals were
locked in a gas chamber and exposed to mustard gas and lewisite.
1945
Project Paperclip is initiated. The U.S. State Department, Army intelligence,
and the CIA recruit Nazi scientists and offer them immunity and secret
identities in exchange for work on top secret government projects in the
United
States.
"Program F" is implemented by the U.S. Atomic Energy Commission (AEC).
This is
the most extensive U.S. study of the health effects of fluoride, which was the
key chemical component in atomic bomb production. One of the most toxic
chemicals known to man, fluoride, it is found, causes marked adverse effects
to
the central nervous system but much of the information is squelched in the
name
of national security because of fear that lawsuits would undermine full-scale
production of atomic bombs.
1946
Patients in VA hospitals are used as guinea pigs for medical experiments. In
order to allay suspicions, the order is given to change the word
"experiments"
to "investigations" or "observations" whenever reporting a
medical study
performed in one of the nation's veteran's hospitals.
1947
Colonel E.E. Kirkpatrick of the U.S. Atomic Energy Comission issues a secret
document (Document 07075001, January 8, 1947) stating that the agency will
begin administering intravenous doses of radioactive substances to human
subjects.
The CIA begins its study of LSD as a potential weapon for use by American
intelligence. Human subjects (both civilian and military) are used with and
without their knowledge.
1950
Department of Defense begins plans to detonate nuclear weapons in desert areas
and monitor downwind residents for medical problems and mortality rates.
In an experiment to determine how susceptible an American city would be to
biological attack, the U.S. Navy sprays a cloud of bacteria from ships over
San
Franciso. Monitoring devices are situated throughout the city in order to test
the extent of infection. Many residents become ill with pneumonia-like
symptoms.
1951
Department of Defense begins open air tests using disease-producing bacteria
and viruses. Tests last through 1969 and there is concern that people in the
surrounding areas have been exposed.
1953
U.S. military releases clouds of zinc cadmium sulfide gas over Winnipeg, St.
Louis, Minneapolis, Fort Wayne, the Monocacy River Valley in Maryland, and
Leesburg, Virginia. Their intent is to determine how efficiently they could
disperse chemical agents.
Joint Army-Navy-CIA experiments are conducted in which tens of thousands of
people in New York and San Francisco are exposed to the airborne germs
Serratia
marcescens and Bacillus glogigii.
CIA initiates Project MKULTRA. This is an eleven year research program
designed
to produce and test drugs and biological agents that would be used for mind
control and behavior modification. Six of the subprojects involved testing the
agents on unwitting human beings.
1955
The CIA, in an experiment to test its ability to infect human populations with
biological agents, releases a bacteria withdrawn from the Army's biological
warfare arsenal over Tampa Bay, Fl.
Army Chemical Corps continues LSD research, studying its potential use as a
chemical incapacitating agent. More than 1,000 Americans participate in the
tests, which continue until 1958.
1956
U.S. military releases mosquitoes infected with Yellow Fever over Savannah, Ga
and Avon Park, Fl. Following each test, Army agents posing as public health
officials test victims for effects.
1958
LSD is tested on 95 volunteers at the Army's Chemical Warfare Laboratories for
its effect on intelligence.
1960
The Army Assistant Chief-of-Staff for Intelligence (ACSI) authorizes field
testing of LSD in Europe and the Far East. Testing of the european population
is code named Project THIRD CHANCE; testing of the Asian population is code
named Project DERBY HAT.
1965
Project CIA and Department of Defense begin Project MKSEARCH, a program to
develop a capability to manipulate human behavior through the use of
mind-altering drugs.
1965
Prisoners at the Holmesburg State Prison in Philadelphia are subjected to
dioxin, the highly toxic chemical component of Agent Orange used in Viet Nam.
The men are later studied for development of cancer, which indicates that
Agent
Orange had been a suspected carcinogen all along.
1966
CIA initiates Project MKOFTEN, a program to test the toxicological effects of
certain drugs on humans and animals.
U.S. Army dispenses Bacillus subtilis variant niger throughout the New York
City subway system. More than a million civilians are exposed when army
scientists drop lightbulbs filled with the bacteria onto ventilation grates.
1967
CIA and Department of Defense implement Project MKNAOMI, successor to MKULTRA
and designed to maintain, stockpile and test biological and chemical weapons.
1968
CIA experiments with the possibility of poisoning drinking water by injecting
chemicals into the water supply of the FDA in Washington, D.C.
1969
Dr. Robert MacMahan of the Department of Defense requests from congress $10
million to develop, within 5 to 10 years, a synthetic biological agent to
which
no natural immunity exists.
1970
Funding for the synthetic biological agent is obtained under H.R. 15090. The
project, under the supervision of the CIA, is carried out by the Special
Operations Division at Fort Detrick, the army's top secret biological weapons
facility. Speculation is raised that molecular biology techniques are used to
produce AIDS-like retroviruses.
United States intensifies its development of "ethnic weapons"
(Military
Review,
Nov., 1970), designed to selectively target and eliminate specific ethnic
groups who are susceptible due to genetic differences and variations in DNA.
1975
The virus section of Fort Detrick's Center for Biological Warfare Research is
renamed the Fredrick Cancer Research Facilities and placed under the
supervision of the National Cancer Institute (NCI) . It is here that a special
virus cancer program is initiated by the U.S. Navy, purportedly to develop
cancer-causing viruses. It is also here that retrovirologists isolate a virus
to which no immunity exists. It is later named HTLV (Human T-cell Leukemia
Virus).
1977
Senate hearings on Health and Scientific Research confirm that 239 populated
areas had been contaminated with biological agents between 1949 and 1969. Some
of the areas included San Francisco, Washington, D.C., Key West, Panama City,
Minneapolis, and St. Louis.
1978
Experimental Hepatitis B vaccine trials, conducted by the CDC, begin in New
York, Los Angeles and San Francisco. Ads for research subjects specifically
ask
for promiscuous homosexual men.
1981
First cases of AIDS are confirmed in homosexual men in New York, Los Angeles
and San Francisco, triggering speculation that AIDS may have been introduced
via the Hepatitis B vaccine
1985
According to the journal Science (227:173-177), HTLV and VISNA, a fatal sheep
virus, are very similar, indicating a close taxonomic and evolutionary
relationship.
1986
According to the Proceedings of the National Academy of Sciences
(83:4007-4011), HIV and VISNA are highly similar and share all structural
elements, except for a small segment which is nearly identical to HTLV. This
leads to speculation that HTLV and VISNA may have been linked to produce a new
retrovirus to which no natural immunity exists.
A report to Congress reveals that the U.S. Government's current generation of
biological agents includes: modified viruses, naturally occurring toxins, and
agents that are altered through genetic engineering to change immunological
character and prevent treatment by all existing vaccines.
1987
Department of Defense admits that, despite a treaty banning research and
development of biological agents, it continues to operate research facilities
at 127 facilities and universities around the nation.
1990
More than 1500 six-month old black and hispanic babies in Los Angeles are
given
an "experimental" measles vaccine that had never been licensed for use
in the
United States. CDC later admits that parents were never informed that the
vaccine being injected to their children was experimental.
1994
With a technique called "gene tracking," Dr. Garth Nicolson at the MD
Anderson
Cancer Center in Houston, TX discovers that many returning Desert Storm
veterans are infected with an altered strain of Mycoplasma incognitus, a
microbe commonly used in the production of biological weapons. Incorporated
into its molecular structure is 40 percent of the HIV protein coat, indicating
that it had been man-made.
Senator John D. Rockefeller issues a report revealing that for at least 50
years the Department of Defense has used hundreds of thousands of military
personnel in human experiments and for intentional exposure to dangerous
substances. Materials included mustard and nerve gas, ionizing radiation,
psychochemicals, hallucinogens, and drugs used during the Gulf War .
1995
U.S. Government admits that it had offered Japanese war criminals and
scientists who had performed human medical experiments salaries and immunity
from prosecution in exchange for data on biological warfare research.
Dr. Garth Nicolson, uncovers evidence that the biological agents used during
the Gulf War had been manufactured in Houston, TX and Boca Raton, Fl and
tested
on prisoners in the Texas Department of Corrections.
1996
Department of Defense admits that Desert Storm soldiers were exposed to
chemical agents.
1997
Eighty-eight members of Congress sign a letter demanding an investigation into
bioweapons use & Gulf War Syndrome.
<A HREF="http://hometown.aol.com/agoliszek/page2/index.htm">
http://hometown.aol.com/agoliszek/page2/index.htm</A>
>>
WOW I am amazed that all this has been going on for all these years and there
has been no press on any of this stuff scares the stuff out of me.
Dat crazy Hippy Hepper YOOPER Pete G
"When one refuses to look at things from another point of view, they have
narrowed their own perspective down to a pin prick." pmg.
-----------------
Forwarded Message:
Subj: A History of Secret U.S. Government Programs -- WOW, is
this for
REAL?
Date: 01/06/2001 6:03:00 AM Central Standard Time
From: Wix58@aol.com
Reply-to: Wix58@aol.com
To: HEPC@hepatitis.org.uk (HEPC List)
************************************************
To UNSUBSCRIBE from the Main List go to
http://www.hepatitis.org.uk/hepc-list/unsub_main_list.htm
------------------------------------------------
Do not send unsubscribing requests to the list
Try to do it yourself by going to the link above.
If stuck, write PRIVATELY to crina@vossnet.co.uk
************************************************
Date: Sat, 6 Jan 2001 06:18:30 EST
From: Wix58@aol.com
Subject: A History of Secret U.S. Government Programs -- WOW, is this for
REAL?
A History of Secret U.S. Government Programs
The following is a list of this century's most controversial government
activities. It will be updated regularly in order to keep readers abreast of
newly declassified materials:
1931
Dr. Cornelius Rhoads, under the auspices of the Rockefeller Institute for
Medical Investigations, infects human subjects with cancer cells. He later
goes
on to establish the U.S. Army Biological Warfare facilities in Maryland, Utah,
and Panama, and is named to the U.S. Atomic Energy Commission. While there, he
begins a series of radiation exposure experiments on American soldiers and
civilian hospital patients.
1932
The Tuskegee Syphilis Study begins. 200 black men diagnosed with syphilis are
never told of their illness, are denied treatment, and instead are used as
human guinea pigs in order to follow the progression and symptoms of the
disease. They all subsequently die from syphilis, their families never told
that they could have been treated.
1935
The Pellagra Incident. After millions of individuals die from Pellagra over a
span of two decades, the U.S. Public Health Service finally acts to stem the
disease. The director of the agency admits it had known for at least 20 years
that Pellagra is caused by a niacin deficiency but failed to act since most of
the deaths occured within poverty-striken black populations.
1940
Four hundred prisoners in Chicago are infected with Malaria in order to study
the effects of new and experimental drugs to combat the disease. Nazi doctors
later on trial at Nuremberg cite this American study to defend their own
actions during the Holocaust.
1942
Chemical Warfare Services begins mustard gas experiments on approximately
4,000
servicemen. The experiments continue until 1945 and made use of Seventh Day
Adventists who chose to become human guinea pigs rather than serve on active
duty.
1943
In response to Japan's full-scale germ warfare program, the U.S. begins
research on biological weapons at Fort Detrick, MD.
1944
U.S. Navy uses human subjects to test gas masks and clothing. Individuals were
locked in a gas chamber and exposed to mustard gas and lewisite.
1945
Project Paperclip is initiated. The U.S. State Department, Army intelligence,
and the CIA recruit Nazi scientists and offer them immunity and secret
identities in exchange for work on top secret government projects in the
United
States.
"Program F" is implemented by the U.S. Atomic Energy Commission (AEC).
This is
the most extensive U.S. study of the health effects of fluoride, which was the
key chemical component in atomic bomb production. One of the most toxic
chemicals known to man, fluoride, it is found, causes marked adverse effects
to
the central nervous system but much of the information is squelched in the
name
of national security because of fear that lawsuits would undermine full-scale
production of atomic bombs.
1946
Patients in VA hospitals are used as guinea pigs for medical experiments. In
order to allay suspicions, the order is given to change the word
"experiments"
to "investigations" or "observations" whenever reporting a
medical study
performed in one of the nation's veteran's hospitals.
1947
Colonel E.E. Kirkpatrick of the U.S. Atomic Energy Comission issues a secret
document (Document 07075001, January 8, 1947) stating that the agency will
begin administering intravenous doses of radioactive substances to human
subjects.
The CIA begins its study of LSD as a potential weapon for use by American
intelligence. Human subjects (both civilian and military) are used with and
without their knowledge.
1950
Department of Defense begins plans to detonate nuclear weapons in desert areas
and monitor downwind residents for medical problems and mortality rates.
In an experiment to determine how susceptible an American city would be to
biological attack, the U.S. Navy sprays a cloud of bacteria from ships over
San
Franciso. Monitoring devices are situated throughout the city in order to test
the extent of infection. Many residents become ill with pneumonia-like
symptoms.
1951
Department of Defense begins open air tests using disease-producing bacteria
and viruses. Tests last through 1969 and there is concern that people in the
surrounding areas have been exposed.
1953
U.S. military releases clouds of zinc cadmium sulfide gas over Winnipeg, St.
Louis, Minneapolis, Fort Wayne, the Monocacy River Valley in Maryland, and
Leesburg, Virginia. Their intent is to determine how efficiently they could
disperse chemical agents.
Joint Army-Navy-CIA experiments are conducted in which tens of thousands of
people in New York and San Francisco are exposed to the airborne germs
Serratia
marcescens and Bacillus glogigii.
CIA initiates Project MKULTRA. This is an eleven year research program
designed
to produce and test drugs and biological agents that would be used for mind
control and behavior modification. Six of the subprojects involved testing the
agents on unwitting human beings.
1955
The CIA, in an experiment to test its ability to infect human populations with
biological agents, releases a bacteria withdrawn from the Army's biological
warfare arsenal over Tampa Bay, Fl.
Army Chemical Corps continues LSD research, studying its potential use as a
chemical incapacitating agent. More than 1,000 Americans participate in the
tests, which continue until 1958.
1956
U.S. military releases mosquitoes infected with Yellow Fever over Savannah, Ga
and Avon Park, Fl. Following each test, Army agents posing as public health
officials test victims for effects.
1958
LSD is tested on 95 volunteers at the Army's Chemical Warfare Laboratories for
its effect on intelligence.
1960
The Army Assistant Chief-of-Staff for Intelligence (ACSI) authorizes field
testing of LSD in Europe and the Far East. Testing of the european population
is code named Project THIRD CHANCE; testing of the Asian population is code
named Project DERBY HAT.
1965
Project CIA and Department of Defense begin Project MKSEARCH, a program to
develop a capability to manipulate human behavior through the use of
mind-altering drugs.
1965
Prisoners at the Holmesburg State Prison in Philadelphia are subjected to
dioxin, the highly toxic chemical component of Agent Orange used in Viet Nam.
The men are later studied for development of cancer, which indicates that
Agent
Orange had been a suspected carcinogen all along.
1966
CIA initiates Project MKOFTEN, a program to test the toxicological effects of
certain drugs on humans and animals.
U.S. Army dispenses Bacillus subtilis variant niger throughout the New York
City subway system. More than a million civilians are exposed when army
scientists drop lightbulbs filled with the bacteria onto ventilation grates.
1967
CIA and Department of Defense implement Project MKNAOMI, successor to MKULTRA
and designed to maintain, stockpile and test biological and chemical weapons.
1968
CIA experiments with the possibility of poisoning drinking water by injecting
chemicals into the water supply of the FDA in Washington, D.C.
1969
Dr. Robert MacMahan of the Department of Defense requests from congress $10
million to develop, within 5 to 10 years, a synthetic biological agent to
which
no natural immunity exists.
1970
Funding for the synthetic biological agent is obtained under H.R. 15090. The
project, under the supervision of the CIA, is carried out by the Special
Operations Division at Fort Detrick, the army's top secret biological weapons
facility. Speculation is raised that molecular biology techniques are used to
produce AIDS-like retroviruses.
United States intensifies its development of "ethnic weapons"
(Military
Review,
Nov., 1970), designed to selectively target and eliminate specific ethnic
groups who are susceptible due to genetic differences and variations in DNA.
1975
The virus section of Fort Detrick's Center for Biological Warfare Research is
renamed the Fredrick Cancer Research Facilities and placed under the
supervision of the National Cancer Institute (NCI) . It is here that a special
virus cancer program is initiated by the U.S. Navy, purportedly to develop
cancer-causing viruses. It is also here that retrovirologists isolate a virus
to which no immunity exists. It is later named HTLV (Human T-cell Leukemia
Virus).
1977
Senate hearings on Health and Scientific Research confirm that 239 populated
areas had been contaminated with biological agents between 1949 and 1969. Some
of the areas included San Francisco, Washington, D.C., Key West, Panama City,
Minneapolis, and St. Louis.
1978
Experimental Hepatitis B vaccine trials, conducted by the CDC, begin in New
York, Los Angeles and San Francisco. Ads for research subjects specifically
ask
for promiscuous homosexual men.
1981
First cases of AIDS are confirmed in homosexual men in New York, Los Angeles
and San Francisco, triggering speculation that AIDS may have been introduced
via the Hepatitis B vaccine
1985
According to the journal Science (227:173-177), HTLV and VISNA, a fatal sheep
virus, are very similar, indicating a close taxonomic and evolutionary
relationship.
1986
According to the Proceedings of the National Academy of Sciences
(83:4007-4011), HIV and VISNA are highly similar and share all structural
elements, except for a small segment which is nearly identical to HTLV. This
leads to speculation that HTLV and VISNA may have been linked to produce a new
retrovirus to which no natural immunity exists.
A report to Congress reveals that the U.S. Government's current generation of
biological agents includes: modified viruses, naturally occurring toxins, and
agents that are altered through genetic engineering to change immunological
character and prevent treatment by all existing vaccines.
1987
Department of Defense admits that, despite a treaty banning research and
development of biological agents, it continues to operate research facilities
at 127 facilities and universities around the nation.
1990
More than 1500 six-month old black and hispanic babies in Los Angeles are
given
an "experimental" measles vaccine that had never been licensed for use
in the
United States. CDC later admits that parents were never informed that the
vaccine being injected to their children was experimental.
1994
With a technique called "gene tracking," Dr. Garth Nicolson at the MD
Anderson
Cancer Center in Houston, TX discovers that many returning Desert Storm
veterans are infected with an altered strain of Mycoplasma incognitus, a
microbe commonly used in the production of biological weapons. Incorporated
into its molecular structure is 40 percent of the HIV protein coat, indicating
that it had been man-made.
Senator John D. Rockefeller issues a report revealing that for at least 50
years the Department of Defense has used hundreds of thousands of military
personnel in human experiments and for intentional exposure to dangerous
substances. Materials included mustard and nerve gas, ionizing radiation,
psychochemicals, hallucinogens, and drugs used during the Gulf War .
1995
U.S. Government admits that it had offered Japanese war criminals and
scientists who had performed human medical experiments salaries and immunity
from prosecution in exchange for data on biological warfare research.
Dr. Garth Nicolson, uncovers evidence that the biological agents used during
the Gulf War had been manufactured in Houston, TX and Boca Raton, Fl and
tested
on prisoners in the Texas Department of Corrections.
1996
Department of Defense admits that Desert Storm soldiers were exposed to
chemical agents.
1997
Eighty-eight members of Congress sign a letter demanding an investigation into
bioweapons use & Gulf War Syndrome.
<A HREF="http://hometown.aol.com/agoliszek/page2/index.htm">
http://hometown.aol.com/agoliszek/page2/index.htm</A>
*********************************Page 13
_